Basic Information
| LncRNA/CircRNA Name | RP11-552M11.4 |
| Synonyms | NA |
| Region | GRCh38_1:111438638-111441364 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Cervical Cancer |
| ICD-0-3 | C53 |
| Methods | Luciferase reporter assay, RIP |
| Sample | cc tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | Additionally, CC patients with high lncRNA RP11-552M11.4 level suffered from poor clinical outcomes. |
| Pubmed ID | 30790638 |
| Year | 2019 |
| Title | Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling. |
External Links
| Links for RP11-552M11.4 | GenBank HGNC NONCODE |
| Links for Cervical Cancer | OMIM COSMIC |